136 related articles for article (PubMed ID: 14630371)
1. Measurement of plasma pristanic, phytanic and very long chain fatty acids by liquid chromatography-electrospray tandem mass spectrometry for the diagnosis of peroxisomal disorders.
Johnson DW; Trinh MU; Oe T
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(1):159-62. PubMed ID: 14630371
[TBL] [Abstract][Full Text] [Related]
2. A new multiplex method for the diagnosis of peroxisomal disorders allowing simultaneous determination of plasma very-long-chain fatty acids, phytanic, pristanic, docosahexaenoic and bile acids by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Semeraro M; Rizzo C; Boenzi S; Cappa M; Bertini E; Antonetti G; Dionisi-Vici C
Clin Chim Acta; 2016 Jul; 458():159-64. PubMed ID: 27189059
[TBL] [Abstract][Full Text] [Related]
3. Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders.
Al-Dirbashi OY; Santa T; Rashed MS; Al-Hassnan Z; Shimozawa N; Chedrawi A; Jacob M; Al-Mokhadab M
J Lipid Res; 2008 Aug; 49(8):1855-62. PubMed ID: 18441019
[TBL] [Abstract][Full Text] [Related]
4. A rapid screening procedure for the diagnosis of peroxisomal disorders: quantification of very long-chain fatty acids, as dimethylaminoethyl esters, in plasma and blood spots, by electrospray tandem mass spectrometry.
Johnson DW
J Inherit Metab Dis; 2000 Jul; 23(5):475-86. PubMed ID: 10947202
[TBL] [Abstract][Full Text] [Related]
5. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
[TBL] [Abstract][Full Text] [Related]
6. Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry.
Vreken P; van Lint AE; Bootsma AH; Overmars H; Wanders RJ; van Gennip AH
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):281-7. PubMed ID: 9746242
[TBL] [Abstract][Full Text] [Related]
7. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
8. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
[TBL] [Abstract][Full Text] [Related]
9. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
De Biase I; Pasquali M
Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
[TBL] [Abstract][Full Text] [Related]
10. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
[TBL] [Abstract][Full Text] [Related]
11. Analysis of pristanic acid beta-oxidation intermediates in plasma from healthy controls and patients affected with peroxisomal disorders by stable isotope dilution gas chromatography mass spectrometry.
Verhoeven NM; Schor DS; Struys EA; Jansen EE; ten Brink HJ ; Wanders RJ; Jakobs C
J Lipid Res; 1999 Feb; 40(2):260-6. PubMed ID: 9925655
[TBL] [Abstract][Full Text] [Related]
12. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
[TBL] [Abstract][Full Text] [Related]
13. Pre- and postnatal diagnosis of peroxisomal disorders using stable-isotope dilution gas chromatography--mass spectrometry.
Verhoeven NM; Kulik W; van den Heuvel CM; Jakobs C
J Inherit Metab Dis; 1995; 18 Suppl 1():45-60. PubMed ID: 9053555
[TBL] [Abstract][Full Text] [Related]
14. Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders.
Subhashini P; Jaya Krishna S; Usha Rani G; Sushma Chander N; Maheshwar Reddy G; Naushad SM
J Biochem; 2019 Jan; 165(1):67-73. PubMed ID: 30295825
[TBL] [Abstract][Full Text] [Related]
15. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
[TBL] [Abstract][Full Text] [Related]
16. Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.
Hall NA; Lynes GW; Hjelm NM
Clin Chem; 1988 Jun; 34(6):1041-5. PubMed ID: 2454167
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of peroxisomal disorders by analysis of phytanic and pristanic acids in stored blood spots collected at neonatal screening.
ten Brink HJ; van den Heuvel CM; Christensen E; Largillière C; Jakobs C
Clin Chem; 1993 Sep; 39(9):1904-6. PubMed ID: 8375069
[TBL] [Abstract][Full Text] [Related]
18. Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
Scott AI
Methods Mol Biol; 2022; 2546():501-508. PubMed ID: 36127617
[TBL] [Abstract][Full Text] [Related]
19. Ataxia associated with increased plasma concentrations of pristanic acid, phytanic acid and C27 bile acids but normal fibroblast branched-chain fatty acid oxidation.
Clayton PT; Johnson AW; Mills KA; Lynes GW; Wilson J; Casteels M; Mannaerts G
J Inherit Metab Dis; 1996; 19(6):761-8. PubMed ID: 8982949
[TBL] [Abstract][Full Text] [Related]
20. Phytanic acid alpha-oxidation: accumulation of 2-hydroxyphytanic acid and absence of 2-oxophytanic acid in plasma from patients with peroxisomal disorders.
ten Brink HJ; Schor DS; Kok RM; Poll-The BT; Wanders RJ; Jakobs C
J Lipid Res; 1992 Oct; 33(10):1449-57. PubMed ID: 1385561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
